Myrexis (formerly known as Myriad Pharmaceuticals) is a molecular biopharmaceutical company. It discovers, develops, and commercializes therapies for the treatment of cancer. The company is also engaged in identifying, evaluating, and making financial investments in life sciences assets.
|Share Price (Mar 2020)||$0||(+3%)|
Market capitalization (27-Mar-2020)
Closing stock price (27-Mar-2020)
When was Myrexis founded?
Myrexis was founded in 1999.
Who are Myrexis competitors?
Competitors of Myrexis include Mirati Therapeutics, Merrimack Pharmaceuticals and CytomX Therapeutics.
Receive alerts for 300+ data fields across thousands of companies